A Propensity Score-Adjusted Comparison of Lenalidomide plus R-CHOP Versus R-CHOP for MYC-Rearranged DLBCL Patients

被引:0
|
作者
de Jonge, A. Vera [1 ]
van Werkhoven, Erik D. [2 ]
Dinmohamed, Avinash G. [3 ]
Nijland, Marcel [4 ,5 ]
Zwinderman, Aeilko H. [6 ]
Bossuyt, Patrick M. [7 ]
Veldhuis, Martine S. [8 ]
Rutten, Emma G. G. M. [9 ]
Mous, Rogier [10 ]
Vermaat, Joost S. P. [11 ]
Sandberg, Yorick [12 ]
de Jongh, Eva [13 ]
Bilgin, Yavuz M. [14 ]
Boersma, Rinske [15 ]
Koene, Harry R. [16 ]
Kersten, Marie Jose [17 ]
de Jong, Daphne [18 ]
Chamuleau, Martine E. D. [1 ]
机构
[1] Vrije Univ Amsterdam, Canc Ctr Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands
[2] Erasmus MC, Hovon Data Ctr, Dept Hematol, Canc Inst, Rotterdam, Netherlands
[3] Netherlands Comprehens Canc Org IKNL, Dept Res & Dev, Utrecht, Netherlands
[4] Univ Med Ctr Groningen, Dept Hematol, Groningen, Netherlands
[5] Univ Groningen, Groningen, Netherlands
[6] Univ Amsterdam, Amsterdam UMC, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands
[7] Locat Univ Amsterdam, Dept Clin Epidemiol, Amsterdam UMC, Biostat, Amsterdam, Netherlands
[8] Locat Vrije Univ Amsterdam, Dept Hematol, Amsterdam UMC, Amsterdam, Netherlands
[9] Locat Vrije Univ Amsterdam, Dept Pathol, Amsterdam UMC, Amsterdam, Netherlands
[10] Univ Med Ctr Utrecht, Dept Hematol, Utrecht, Netherlands
[11] Leiden Univ, Dept Hematol, Med Ctr, Leiden, Netherlands
[12] Maasstad Hosp, Dept Internal Med, Rotterdam, Netherlands
[13] Albert Schweitzer Hosp, Dept Hematol, Dordrecht, Netherlands
[14] Admiraal de Ruijter Hosp, Dept Internal Med, Goes, Netherlands
[15] Amphia Hosp, Dept Internal Med, Breda, Netherlands
[16] St Antonius Hosp, Dept Hematol, Nieuwegein, Netherlands
[17] Acad Med Ctr, Dept Hematol, Amsterdam, Netherlands
[18] Vrije Univ Amsterdam, Amsterdam UMC, Dept Pathol, Canc Ctr Amsterdam, Amsterdam, Netherlands
关键词
D O I
10.1182/blood-2022-163204
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2059 / 2060
页数:2
相关论文
共 50 条
  • [1] A non-randomized risk-adjusted comparison of lenalidomide plus R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
    de Jonge, A. Vera
    van Werkhoven, Erik
    Dinmohamed, Avinash G.
    Nijland, Marcel
    Zwinderman, Aeilko H.
    Bossuyt, Patrick M.
    Veldhuis, Martine S.
    Rutten, Emma G. G. M.
    Mous, Rogier
    Vermaat, Joost S. P.
    Sandberg, Yorick
    de Jongh, Eva
    Bilgin, Yavuz M.
    Boersma, Rinske
    Koene, Harry
    Kersten, Marie Jose
    de Jong, Daphne
    Chamuleau, Martine E. D.
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [2] A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients
    A. Vera de Jonge
    Erik van Werkhoven
    Avinash G. Dinmohamed
    Marcel Nijland
    Aeilko H. Zwinderman
    Patrick M. Bossuyt
    Martine S. Veldhuis
    Emma G. G. M. Rutten
    Rogier Mous
    Joost S. P. Vermaat
    Yorick Sandberg
    Eva de Jongh
    Yavuz M. Bilgin
    Rinske Boersma
    Harry Koene
    Marie José Kersten
    Daphne de Jong
    Martine E. D. Chamuleau
    Blood Cancer Journal, 13
  • [3] R-CHOP Plus Bortezomib Unpromising in Patients With DLBCL, While an Early Trial of R-CHOP Plus Everolimus Shows Remarkable Results
    不详
    AMERICAN JOURNAL OF MANAGED CARE, 2016, 22 : 9 - 11
  • [4] MYC-rearranged lymphomas other than Burkitt: Comparison between R-CHOP and Burldtt-type immunochemotherapy
    Joao Baptista, Maria
    Tapia, Gustavo
    Hernandez-Rivas, Jose-Angel
    Martinez-Trillos, Alejandra
    Mate, Jose-Luis
    Navarro, Jose-Tomas
    MEDICINA CLINICA, 2017, 149 (08): : 339 - 342
  • [5] Lenalidomide in combination with R-CHOP in lymphoma
    Bagcchi, Sanjeet
    LANCET ONCOLOGY, 2014, 15 (11): : E476 - E476
  • [6] Prognostic PET after R-CHOP in DLBCL
    不详
    JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (04) : 17N - 17N
  • [7] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed O. Ayed
    Annalisa Chiappella
    Levi Pederson
    Betsy R. Laplant
    Angela Giovanna Congiu
    Gianluca Gaidano
    Michele Spina
    Alessandro Re
    Federica Cavallo
    Gerardo Musuraca
    William R. Macon
    Thomas Witzig
    Umberto Vitolo
    Grzegorz S. Nowakowski
    Blood Cancer Journal, 8
  • [8] R-CHOP in DLBCL: priming for success Comment
    Hertzberg, Mark
    BLOOD, 2022, 139 (08) : 1121 - 1122
  • [9] CNS relapse in patients with DLBCL treated with lenalidomide plus R-CHOP (R2CHOP): analysis from two phase 2 studies
    Ayed, Ayed O.
    Chiappella, Annalisa
    Pederson, Levi
    Laplant, Betsy R.
    Congiu, Angela Giovanna
    Gaidano, Gianluca
    Spina, Michele
    Re, Alessandro
    Cavallo, Federica
    Musuraca, Gerardo
    Macon, William R.
    Witzig, Thomas
    Vitolo, Umberto
    Nowakowski, Grzegorz S.
    BLOOD CANCER JOURNAL, 2018, 8
  • [10] Early R-CHOP therapy assessment using FLT PET/CT in patients with DLBCL treated with R-CHOP - the initial results
    Malkowski, B.
    Chmielowska, E.
    Olejnik, M.
    Pietrzak, T.
    Makarewicz, A.
    Kachniarz, A.
    Kasprzak, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S250 - S251